Quotient Sciences' Commercial Manufacturing Capabilities
1 September 2025Quotient Sciences offers integrated commercial drug product manufacturing services designed to accelerate time to market and reduce drug product supply chain complexity.
With capabilities spanning solid oral dosage forms, including high-potency APIs (HPAPIs), we support clients through late-phase trials through to commercial launch and sustained, reliable commercial drug product supply. Operating from FDA- and MHRA-approved facilities, Quotient Sciences provides flexible batch sizes and scalable processes to delivery your drug product supply globally.
We are equipped to manage complex drug product manufacturing programs across multiple therapeutic areas, offering agile solutions that reduce supply chain risk and accelerate time to market.